SYK Stock Recent News
SYK LATEST HEADLINES
Here is how Stryker (SYK) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
SYK's second-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (NYSE:SYK ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Jason Beach - Vice President of Finance & Investor Relations Kevin A. Lobo - Chairman, CEO & President Preston Wells - VP & CFO Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Christopher Thomas Pasquale - Nephron Research LLC Danielle Joy Antalffy - UBS Investment Bank, Research Division Joanne Karen Wuensch - Citigroup Inc., Research Division Lawrence H.
Stryker (SYK) came out with quarterly earnings of $3.13 per share, beating the Zacks Consensus Estimate of $3.06 per share. This compares to earnings of $2.81 per share a year ago.
Portage, Michigan, July 31, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2025: Second Quarter Results Reported net sales increased 11.1% to $6.0 billion Organic net sales increased 10.2% Reported operating income margin of 18.5% Adjusted operating income margin (1) increased 110 bps to 25.7% Reported EPS increased 7.0% to $2.29 Adjusted EPS (1) increased 11.4% to $3.13 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 17.3 % 0.6 % 16.7 % 5.7 % 11.0 % Orthopaedics 2.0 0.9 1.1 (7.9) 9
Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.
PORTAGE, Mich. , July 29, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal.
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.